AI coding agent skills library claude-skills ships 345 free, MIT-licensed packages for Claude Code, Codex, Cursor, Gemini CLI ...

Spread the love“`html When it comes to data analysis and visualization, Python stands out as one of the most versatile programming languages available. Whether you’re a data scientist, a student, or ...

Trade Ideas is widely regarded as the gold standard among AI tools for trading in the equities market. Its flagship engine, Holly AI, runs thousands of simulated trades overnight to generate a ranked ...

Crypto exchanges provide developers with APIs to connect with their trading engine and data feeds. The APIs cover a dozen ...

Find the 6 best free inventory management software for small businesses in 2026. We review top tools like Odoo, Zoho, and ...

We've tested the top AI image generation apps to help you find the one that produces the best results for the lowest price. I’ve been writing about consumer technology and video games for more than a ...

Value stream management involves people in the organization to examine workflows and other processes to ensure they are deriving the maximum value from their efforts while eliminating waste — of ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Docs rot faster than fruit. You refactor a function signature on Monday. The docs still show the old signature on Friday. By next month, half your documentation is lying to your users. Formatting is ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...